UKHSA: Risk assessment for Omicron BA.2

The latest risk assessment of the BA.2 strain from the UKHSA.

 

Overall growth advantage – Red: There is evidence of a growth advantage for BA.2 compared to BA.1 in more than one country....More...

UK.GOV: vaccine booster doses wane after just 10 weeks

“The latest data suggests this extra protection starts to wane more rapidly, being about 15 to 25% lower from 10 weeks after the booster dose.”...More...

Preprint: Evidence for a mouse origin of the Omicron variant

Pre-outbreak Omicron mutations in the spike protein significantly overlap with mutations in mouse-adapted SARS-CoV-2.

The molecular docking-based predictions suggested that the RBD of Omicron exhibited higher binding affinity for mouse ACE2 than that of RBD encoded in the reference SARS-CoV-2 genome, further suggesting an evolutionary history in mice (Fig....More...

Plague Island: highest ever UK Covid case rate, Omicron now dominant in London

Another dismal Covid record has been broken in Britain today. More people have tested positive for the virus in one day than ever before....More...

Denmark: ~90% of Omicron cases are double or triple vaccinated *17 UPDATES*

Denmark’s SSI has revealed that the vast majority of people currently infected with the Omicron variant are double or triple vaccinated. ...More...

UKHSA bombshell: Effectiveness of COVID-19 vaccines against the Omicron variant

“Among those who had received 2 doses of [AstraZeneca], there was NO protective effect of vaccination against symptomatic disease with Omicron from 15 weeks after the second dose.”...More...